Open Access Repository

Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population‐based cohort study

Downloads

Downloads per month over past year

Bezabhe, W ORCID: 0000-0002-3028-6949, Bereznicki, LR ORCID: 0000-0003-3974-3437, Radford, J ORCID: 0000-0002-5751-0488, Wimmer, BC ORCID: 0000-0003-3166-7126, Salahudeen, MS ORCID: 0000-0001-9131-7465, Garrahy, E, Bindoff, I ORCID: 0000-0002-8170-8339 and Peterson, GM ORCID: 0000-0002-6764-3882 2022 , 'Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: a population‐based cohort study' , Journal of the American Heart Association, vol. 11 , e023098 , doi: 10.1161/JAHA.121.023098.

[img]
Preview
PDF (Published version)
149254 - Oral a...pdf | Download (604kB)

| Preview

Abstract

Background:We compared the dementia incidence rate between users and nonusers of oral anticoagulants (OACs) in a large cohort of primary care patients with atrial fibrillation.Methods and results:We performed a retrospective study using an Australia-wide primary care data set, MedicineInsight. Patients aged ≥18 years and newly diagnosed with atrial fibrillation between January 1, 2010, and December 31, 2017, and with no recorded history of dementia or stroke were included and followed until December 31, 2018. We applied a propensity score for 1:1 pair matching of baseline covariates and Cox regression for comparing the dementia incidence rates for OAC users and nonusers. Data were analyzed for 18 813 patients with atrial fibrillation (aged 71.9±12.6 years, 47.1% women); 11 419 had a recorded OAC prescription for at least 80% of their follow-up time. During the mean follow-up time of 3.7±2.0 years, 425 patients (2.3%; 95% CI, 2.1%-2.5%) had a documented diagnosis of dementia. After propensity matching, the incidence of dementia was significantly lower in OAC users (hazard ratio [HR], 0.59; 95% CI, 0.44-0.80; PPP=0.002). No significant difference was seen between warfarin users and non-OAC users (HR, 1.08; 95% CI, 0.70-1.70; P=0.723).Conclusions:In patients with atrial fibrillation, direct-acting oral anticoagulant use may result in a lower incidence of dementia compared with treatment with either warfarin or no anticoagulant.

Item Type: Article
Authors/Creators:Bezabhe, W and Bereznicki, LR and Radford, J and Wimmer, BC and Salahudeen, MS and Garrahy, E and Bindoff, I and Peterson, GM
Keywords: atrial fibrillation, dementia, direct-acting oral anticoagulants, oral anticoagulants, warfarin
Journal or Publication Title: Journal of the American Heart Association
Publisher: Wiley-Blackwell Publishing, Inc
ISSN: 2047-9980
DOI / ID Number: 10.1161/JAHA.121.023098
Copyright Information:

© 2022 The Authors. Published on behalf of the American Heart Association, Inc., by WileyAttribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License, (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP